Related Funds
| Fund Name | Location |
| 400 Capital Management | New York, New York, United States |
| Benchmark Capital Advisory UK | Horsham, United Kingdom, West Sussex |
| Cor Group | Finland, North Ostrobothnia, Oulu |
| Deep Blue Ventures | - |
| DUMAC | East Syracuse, New York, United States |
| Helvetia Venture Fund | Basel, Basel-Stadt, Switzerland |
| Israel Growth Partners | Israel, Ramat HaSharon, Tel Aviv |
| Marc Bell Ventures | Boca Raton, Florida, United States |
| Midwest Venture Alliance | Kansas, United States, Wichita |
| New Energy Technology | Australia, Perth, Western Australia |
| New England Business Association (formerly Smaller Business Association of New England) | - |
| ORCAS | Florida, Miami, United States |
| Persimmon Hill | - |
| Revolt Ventures | England, London, United Kingdom |
| Sage Technologies | China, Hong Kong, Kowloon |
| Shengxia Guangnian | Chengdu, China, Sichuan |
| Spin Master | Canada, Ontario, Toronto |
| Texas Instruments | Dallas, Texas, United States |
| Venture Accelerator | Nelson, Nelson, New Zealand |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Curar Animal Therapeutics | $363K | 14 Jun 2013 | England |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Curar Animal Therapeutics | $363K | 14 Jun 2013 | England |
